Shaker S[au] - Search Results

Year	Number of Results
1972	1
1990	1
1992	1
1998	2
1999	1
2001	1
2002	1
2003	2
2004	7
2005	3
2006	2
2007	2
2008	5
2009	4
2010	7
2011	5
2012	3
2013	2
2014	6
2015	8
2016	8
2017	4
2018	13
2019	11
2020	14
2021	26
2022	12

1

Idiopathic Pulmonary Fibrosis: Best Practice in Monitoring and Managing a Relentless Fibrotic Disease.

Wuyts WA, Wijsenbeek M, Bondue B, Bouros D, Bresser P, Robalo Cordeiro C, Hilberg O, Magnusson J, Manali ED, Morais A, Papiris S, Shaker S, Veltkamp M, Bendstrup E. Wuyts WA, et al. Among authors: shaker s. Respiration. 2020;99(1):73-82. doi: 10.1159/000504763. Epub 2019 Dec 12. Respiration. 2020. PMID: 31830755 Free PMC article. Review.

2

Eureka?

Stoel BC, Dirksen A, Stockley RA, Parr D, Piitulainen E, Shaker SB, Russi EW, Bakker ME, Reiber JH, Stolk J. Stoel BC, et al. Among authors: shaker sb. Radiology. 2011 May;259(2):610-1; author reply 611-2. doi: 10.1148/radiol.11102262. Radiology. 2011. PMID: 21502395 No abstract available.

3

[Asbestosis and pleural plaques].

Lauridsen HL, Bønløkke JH, Davidsen JR, Eldahl F, Huremovic J, Krüger K, Omland Ø, Shaker SB, Sherson D. Lauridsen HL, et al. Among authors: shaker sb. Ugeskr Laeger. 2018 Jun 18;180(25):V10170773. Ugeskr Laeger. 2018. PMID: 29938630 Free article. Review. Danish.

4

Phytochemistry and cardiovascular protective effects of Huang-Qi (Astragali Radix).

Su HF, Shaker S, Kuang Y, Zhang M, Ye M, Qiao X. Su HF, et al. Among authors: shaker s. Med Res Rev. 2021 Jul;41(4):1999-2038. doi: 10.1002/med.21785. Epub 2021 Jan 19. Med Res Rev. 2021. PMID: 33464616 Review.

5

Clusters of comorbidities in idiopathic pulmonary fibrosis.

Prior TS, Hoyer N, Hilberg O, Shaker SB, Davidsen JR, Rasmussen F, Bendstrup E. Prior TS, et al. Among authors: shaker sb. Respir Med. 2021 Aug-Sep;185:106490. doi: 10.1016/j.rmed.2021.106490. Epub 2021 Jun 1. Respir Med. 2021. PMID: 34130097 Free article.

6

Mixed X-Site Formate-Hypophosphite Hybrid Perovskites.

Wu Y, Halat DM, Wei F, Binford T, Seymour ID, Gaultois MW, Shaker S, Wang J, Grey CP, Cheetham AK. Wu Y, et al. Among authors: shaker s. Chemistry. 2018 Aug 6;24(44):11309-11313. doi: 10.1002/chem.201803061. Epub 2018 Jul 13. Chemistry. 2018. PMID: 29920832

7

[Treatment limitations or discontinuation in patients with benign pulmonary diseases].

Sørensen AR, Bendstrup E, Løkke A, Titlestad IL, Jensen JU, Thomsen L, Roberts N, Gjørup P, Shaker S, Gundestrup S, Wilcke T, Weinreich UM, Marsaa K. Sørensen AR, et al. Among authors: shaker s. Ugeskr Laeger. 2018 Sep 24;180(39):V04180270. Ugeskr Laeger. 2018. PMID: 30274574 Free article. Review. Danish.

8

A meta-analysis for association of TNF-α -308G>A polymorphism with susceptibility to Ankylosing Spondylitis.

Mahdinejad-Yazdi M, Sobhan MR, Dastgheib SA, Bahrami R, Shaker SH, Mirjalili H, Sadeghizadeh-Yazdi J, Zare-Shehneh M, Neamatzadeh H. Mahdinejad-Yazdi M, et al. Among authors: shaker sh. J Orthop. 2021 Jul 14;26:79-87. doi: 10.1016/j.jor.2021.07.015. eCollection 2021 Jul-Aug. J Orthop. 2021. PMID: 34349398 Free PMC article. Review.

9

Validation of a derived version of the IPF-specific Saint George's Respiratory Questionnaire.

Prior TS, Hoyer N, Shaker SB, Davidsen JR, Hilberg O, Patel H, Bendstrup E. Prior TS, et al. Among authors: shaker sb. Respir Res. 2021 Oct 5;22(1):259. doi: 10.1186/s12931-021-01853-2. Respir Res. 2021. PMID: 34610840 Free PMC article.

10

Imaging in chronic obstructive pulmonary disease.

Shaker SB, Dirksen A, Bach KS, Mortensen J. Shaker SB, et al. COPD. 2007 Jun;4(2):143-61. doi: 10.1080/15412550701341277. COPD. 2007. PMID: 17530508 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results